AiCure Announces $16M+ Funding Round
Summary
NEW YORK, NY, AiCure, a prominent AI and advanced data analytics company dedicated to enhancing clinical trials, has announced a significant funding round. AiCure announced it has completed a $12 million loan refinancing and has also raised an additional $4 million+ from its existing supportive investors. In 2023 company also expanded its customer base driven in part by its Clinical Site Services offering which provides ongoing monitoring of site- and patient-level data, targeting operational outcome improvements in adherence and compliance. AiCure improves predictability of study timelines, reduces costs and accelerates timelines through remote patient engagement and assessments, including measuring digital biomarkers and real-time monitoring of patient dosing. AiCure is globally recognized and is a recipient of the Scrip Award, AI 100 and Digital Health 150.